Clinical Trial Update: ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating ExAblate Transcranial MRgFUS targeting the globus pallidum for Parkinson's disease; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ExAblate Transcranial MRgFUS (MR-guided focused ultrasound)

Snippet

Sponsor: InSightec | Conditions: Parkinson's Disease | NA | Status: COMPLETED | Results posted: 2022-01-19